Closing Bell: Hls Therapeutics Inc up on Friday (HLS)

In market activity today, Hls Therapeutics Inc shares closed at $3.34 after opening the day at $3.20. It traded at a low of $3.20 to a high of $3.34.

The price advanced 4.37 percent from the previous day's close of $3.20.

During the day across North America, the TSX Composite closed -0.16% at 22690.39, the S&P 500 closed -0.78% at 5544.59, the Dow Jones Industrial Average closed -1.29% at 40665.02 and the Nasdaq Composite closed -0.70% at 17871.22.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

A total of 1,801 shares was traded during the last trading day, with total trades of 4, while having an average volume of 1,766 over 5 days.

The TSX market on the whole today saw 1,821 price advancers against 3,352 declines and 121 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.54 (July 21,2023) and low as $3.18 (July 18,2024). Moreover, in the last 12 months, Hls Therapeutics Inc's shares have shrunken -44.61 percent, while in 2024, they have shrunken -15.44%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $101.81 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc is holding an average recommendation of "Moderate Buy" from 5.00 analysts according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..